J. E. Taylor

1.2k total citations
15 papers, 1000 citations indexed

About

J. E. Taylor is a scholar working on Hematology, Molecular Biology and Epidemiology. According to data from OpenAlex, J. E. Taylor has authored 15 papers receiving a total of 1000 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 5 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in J. E. Taylor's work include Erythropoietin and Anemia Treatment (5 papers), Dialysis and Renal Disease Management (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). J. E. Taylor is often cited by papers focused on Erythropoietin and Anemia Treatment (5 papers), Dialysis and Renal Disease Management (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). J. E. Taylor collaborates with scholars based in United Kingdom, United States and Australia. J. E. Taylor's co-authors include G I Bell, Terry Reisine, Michael Berelowitz, Agnes Schönbrunn, W. Feniuk, Daniël Hoyer, Jacques Epelbaum, A-M O'Carroll, Yogesh Patel and P.P.A. Humphrey and has published in prestigious journals such as The Lancet, Journal of Pharmacology and Experimental Therapeutics and Trends in Pharmacological Sciences.

In The Last Decade

J. E. Taylor

14 papers receiving 963 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. E. Taylor United Kingdom	10	438	420	208	170	161	15	1000
Harold Thibodeaux United States	15	291 0.7×	491 1.2×	170 0.8×	29 0.2×	73 0.5×	25	1.3k
Deepti Navaratna United States	11	125 0.3×	347 0.8×	125 0.6×	32 0.2×	46 0.3×	12	883
Dan Chalothorn United States	16	97 0.2×	581 1.4×	203 1.0×	42 0.2×	50 0.3×	20	970
Seung‐Hun Oh South Korea	20	156 0.4×	274 0.7×	225 1.1×	254 1.5×	43 0.3×	55	1.0k
Julian Cahill United Kingdom	13	191 0.4×	365 0.9×	179 0.9×	48 0.3×	44 0.3×	32	1.5k
Meng Cheong Wong Singapore	16	188 0.4×	212 0.5×	61 0.3×	28 0.2×	66 0.4×	28	822
Keiji Igase Japan	14	104 0.2×	126 0.3×	144 0.7×	25 0.1×	81 0.5×	30	779
Hideaki Akimoto Japan	16	160 0.4×	626 1.5×	86 0.4×	58 0.3×	156 1.0×	28	1.8k
Anil Zechariah Germany	18	211 0.5×	550 1.3×	219 1.1×	18 0.1×	36 0.2×	21	1.2k
J Lian United States	5	262 0.6×	281 0.7×	161 0.8×	15 0.1×	31 0.2×	5	974

Countries citing papers authored by J. E. Taylor

Since Specialization

Citations

This map shows the geographic impact of J. E. Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. E. Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. E. Taylor more than expected).

Fields of papers citing papers by J. E. Taylor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. E. Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. E. Taylor. The network helps show where J. E. Taylor may publish in the future.

Co-authorship network of co-authors of J. E. Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of J. E. Taylor. A scholar is included among the top collaborators of J. E. Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. E. Taylor. J. E. Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Mudge, David W., J. E. Taylor, & Kym M. Bannister. (2005). Hepatic vein stenting for recurrent ascites in polycystic liver and kidney disease. Nephrology Dialysis Transplantation. 20(11). 2566–2568. 3 indexed citations

2.

Taylor, J. E. & I. D. Ansell. (1996). Steroid-sensitive nephrotic syndrome and renal impairment in a patient with sarcoidosis and IgA nephropathy. Nephrology Dialysis Transplantation. 11(2). 355–356. 13 indexed citations

3.

Taylor, J. E., J. J. F. Belch, I. S. Henderson, & W.K. Stewart. (1996). Peripheral microcirculatory blood flow in haemodialysis patients treated with erythropoietin.. PubMed. 15(1). 33–8. 10 indexed citations

4.

Taylor, J. E., Nicola Peat, C.J. Porter, & A G Morgan. (1996). Regular low-dose intravenous iron therapy improves response to erythropoietin in haemodialysis patients. Nephrology Dialysis Transplantation. 11(6). 1079–1083. 83 indexed citations

5.

Taylor, J. E. & I. D. Ansell. (1996). Steroid-sensitive nephrotic syndrome and renal impairment in a patient with sarcoidosis and IgA nephropathy. Nephrology Dialysis Transplantation. 11(2). 355–356.

6.

Wood, Simon, et al.. (1996). A case of non-Hodgkin lymphoma presenting primarily with renal failure. Nephrology Dialysis Transplantation. 11(3). 535–536. 13 indexed citations

7.

Hoyer, Daniël, G I Bell, Michael Berelowitz, et al.. (1995). Classification and nomenclature of somatostatin receptors. Trends in Pharmacological Sciences. 16(3). 86–88. 497 indexed citations

8.

Schetz, John A., et al.. (1995). Distribution and pharmacokinetics of a potent peptide antagonist of parathyroid hormone and parathyroid hormone-related protein in the rat.. Journal of Pharmacology and Experimental Therapeutics. 274(3). 1456–1462. 16 indexed citations

9.

Taylor, J. E., J. J. F. Belch, I. S. Henderson, & W.K. Stewart. (1994). Erythropoietin does not increase whole-blood platelet aggregation in vitro. Nephrology Dialysis Transplantation. 9(5). 556–558. 4 indexed citations

10.

Raynor, K, William A. Murphy, D.H. Coy, et al.. (1993). Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides.. Molecular Pharmacology. 43(6). 838–844. 244 indexed citations

11.

Taylor, J. E., I. S. Henderson, W.K. Stewart, & J. J. F. Belch. (1992). Platelet Aggregation in Erythropoietin Treated Dialysis Patients. Platelets. 3(1). 47–52. 4 indexed citations

12.

Taylor, J. E., et al.. (1991). Whole blood granulocyte aggregation in vitro in dialysis-dependent patients. Blood Coagulation & Fibrinolysis. 2(6). 765–770. 1 indexed citations

13.

Taylor, J. E., I. S. Henderson, W.K. Stewart, & J. J. F. Belch. (1991). Erythropoietin and spontaneous platelet aggregation in haemodialysis patients. The Lancet. 338(8779). 1361–1362. 39 indexed citations

14.

Taylor, J. E., F.V. DeFeudis, & J. P. Moreau. (1989). Bradykinin‐antagonists: Therapeutic perspectives. Drug Development Research. 16(1). 1–11. 28 indexed citations

15.

Taylor, J. E.. (1986). [Neuromediator binding to receptors in the rat brain. The effect of chronic administration of Ginkgo biloba extract].. PubMed. 15(31). 1491–3. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact